AbbVie's R&D expenditure 2012-2023
This statistic illustrates the expenditure of AbbVie on research and development from 2012 to 2023. In 2023, AbbVie significantly increased its R&D expenditure to some 7.7 billion U.S. dollars, compared to 6.5 billion dollars in the year before. Abbot was a U.S.-based global pharmaceutical and healthcare products company, headquartered in Chicago, Illinois. In January 2013, Abbott was separated into two companies: Abbott Laboratories and AbbVie. Abbott Laboratories is now specialized on medical products, while AbbVie is responsible for research-based pharmaceuticals. On May 8, 2020, AbbVie completed the acquisition of Allergan plc.